RESUMEN
OBJECTIVES: Women with terminal cancer are assumed to choose hospice care over aggressive treatment at the end of life. With new chemotherapy and target therapy options, it becomes more difficult to decide between hospice care and aggressive management. It is also crucial to consider the cost increases leading to severe financial burdens on healthcare systems. To better understand treatment options at the individual level, this study set out to describe trends in end-of-life care for the four leading cancers in women in Taiwan. STUDY DESIGN: This was a population-based retrospective cohort study. METHODS: The data source was obtained between January 1, 2000, and December 31, 2013, from Taiwan's National Health Insurance Research Database. We identified 98,575 women with a diagnosis of breast (18,596), colorectal (23,734), liver and biliary (28,795) or lung (27,450) cancer who had died during the study period. Hospital data for services provided in the last 6 months of life, including hospice services and aggressive managements (chemotherapy, frequent hospitalisation, emergency room [ER] visits, intensive care unit [ICU] admission and endotracheal intubation), were collected. RESULTS: Hospice utilisation increased over the study period, with 25.85%, 25.34%, 21.23% and 26.55% of female patients with breast, colorectal, liver and biliary, and lung cancer receiving hospice care, respectively. However, the number of women undergoing aggressive treatments in the last 6 months of life remained high, with the breast cancer group having the highest chemotherapy rate, the colorectal cancer group having frequent hospitalisation and the liver and biliary cancer group having frequent ER visits and ICU admissions. CONCLUSIONS: Increasing hospice utilisation among women with the four most common cancers in Taiwan indicates that hospice services have gradually become well accepted over the past 13 years; however, the real focus is on the ineffective treatment preceding hospice care, and late referral was also a notable problem.
Asunto(s)
Cuidados Paliativos al Final de la Vida/estadística & datos numéricos , Neoplasias/terapia , Cuidado Terminal/estadística & datos numéricos , Anciano , Anciano de 80 o más Años , Neoplasias de la Mama/terapia , Neoplasias Colorrectales/terapia , Femenino , Hospitalización , Humanos , Unidades de Cuidados Intensivos , Neoplasias Hepáticas/terapia , Neoplasias Pulmonares/terapia , Persona de Mediana Edad , Programas Nacionales de Salud , Estudios Retrospectivos , Taiwán , Enfermo TerminalRESUMEN
PURPOSE: Previous epidemiologic studies that focused on the association between open-angle glaucoma (OAG) and dementia showed inconsistent results. In the present study, we explored the association between OAG and dementia in an ethnic Chinese (i.e., Taiwanese) population using a population-based data set. METHODS: We retrieved data on study subjects for this case-control study from the Longitudinal Health Insurance Database 2000. We identified 7770 patients who had a diagnosis of dementia as cases, and 7770 subjects matched in terms of sex and age, which were randomly extracted as controls. A conditional logistic regression conditioned on age group, sex, and index year was used to assess the association of dementia with previously diagnosed OAG among the sampled patients. RESULTS: Of 15,540 patients, 1.70% had prior OAG, including 2.02% of the dementia group and 1.38% of the controls. After adjusting for patient socioeconomic characteristics and comorbid medical disorders, dementia patients were more likely to have had prior OAG than controls (odds ratio (OR): 1.44; 95% confidence interval (CI): 1.12-1.85; P<0.01). In addition, female dementia patients were more likely to have had prior OAG than controls (OR: 1.93; 95% CI: 1.35-2.77; P<0.001), whereas no statistical difference in prior OAG between male dementia patients and controls was found. CONCLUSIONS: Female dementia patients were associated with a higher proportion of prior OAG than were the controls.
Asunto(s)
Demencia/epidemiología , Glaucoma de Ángulo Abierto/epidemiología , Anciano , Anciano de 80 o más Años , Alcoholismo/epidemiología , Pueblo Asiatico/etnología , Estudios de Casos y Controles , Bases de Datos Factuales , Demencia/diagnóstico , Diabetes Mellitus/epidemiología , Femenino , Estudios de Seguimiento , Glaucoma de Ángulo Abierto/diagnóstico , Humanos , Hiperlipidemias/epidemiología , Hipertensión/epidemiología , Masculino , Programas Nacionales de Salud/estadística & datos numéricos , Oportunidad Relativa , Prevalencia , Taiwán/epidemiologíaRESUMEN
Inflammatory markers such as interleukin (IL)-6 and tumour necrosis factor-alpha (TNF-α) are elevated in dialysis patients and can predict cardiovascular events and all-cause mortality. Endotoxin is an important source and also another marker of inflammation in patients with chronic kidney disease. The aim of this study was to evaluate the impact of oral probiotics on serum levels of endotoxemia and cytokines in peritoneal dialysis (PD) patients. The decline of residual renal function, peritonitis episodes, and cardiovascular events were also recorded. From July 2011 to June 2012, a randomised, double-blind, placebo-controlled trial was conducted in PD patients. The intervention group received one capsule of probiotics containing 10(9) cfu Bifobacterium bifidum A218, 10(9) cfu Bifidobacterium catenulatum A302, 10(9) cfu Bifidobacterium longum A101, and 10(9) cfu Lactobacillus plantarum A87 daily for six months, while the placebo group received similar capsules containing maltodextrin for the same duration. Levels of serum TNF-α, interferon gamma, IL-5, IL-6, IL-10, IL-17, and endotoxin were measured before and six months after intervention. 39 patients completed the study (21 in the probiotics group and 18 in the placebo group). In patients receiving probiotics, levels of serum TNF-α, IL-5, IL-6, and endotoxin significantly decreased after six months of treatment, while levels of serum IL-10 significantly increased. In contrast, there were no significant changes in levels of serum cytokines and endotoxin in the placebo group after six months. In addition, the residual renal function was preserved in patients receiving probiotics. In conclusion, probiotics could significantly reduce the serum levels of endotoxin, pro-inflammatory cytokines (TNF-α and IL-6), IL-5, increase the serum levels of anti-inflammatory cytokine (IL-10), and preserve residual renal function in PD patients.
Asunto(s)
Terapia Biológica/métodos , Citocinas/sangre , Endotoxemia/prevención & control , Endotoxinas/sangre , Diálisis Peritoneal , Probióticos/administración & dosificación , Insuficiencia Renal/complicaciones , Adulto , Bifidobacterium/fisiología , Método Doble Ciego , Femenino , Humanos , Lactobacillus plantarum/fisiología , Masculino , Persona de Mediana Edad , Placebos/administración & dosificación , Insuficiencia Renal/terapia , Suero/química , Resultado del TratamientoRESUMEN
Male C57BL/6J mice treated with D-galactose (DG) were used to examine the effects of ergothioneine (EGT), melatonin (MEL), or their combination (EGT+MEL) on learning and memory abilities. The mice were divided into five groups and injected subcutaneously with DG (0.3 mL of 1% DG/mouse) except for group 1 (normal controls). Group 3 was orally supplemented with EGT [0.5 mg/kg body weight (bw)], group 4 with MEL (10 mg/kg bw, p.o.), and group 5 with EGT+MEL. EGT and MEL were provided daily for 88 days, while DG was provided between days 7 to 56. Active avoidance task and Morris water-maze task were used to evaluate learning and memory abilities. DG treatment markedly increased escape latency and decreased the number of avoidance in the active avoidance test, whereas EGT and MEL alone significantly improved the performance. DG also impaired the learning and memory abilities in the water-maze task, and EGT and MEL alone also significantly improved the performance. EGT+MEL produced the strongest effects in both tasks. EGT and MEL alone markedly decreased ß-amyloid protein accumulation in the hippocampus and significantly inhibited lipid peroxidation and maintained glutathione/glutathione disulfide ratio and superoxide dismutase activity in brain tissues of DG-treated mice. MEL alone completely prevented the rise in brain acetylcholine esterase activity induced by DG, whereas EGT and EGT+MEL were only partially effective. Overall, EGT, MEL, and, in particular, the combination of EGT and MEL effectively protect against learning and memory deficits in C57BL/6J mice treated with DG, possibly through attenuation of oxidative damage.
Asunto(s)
Antioxidantes/farmacología , Encéfalo/efectos de los fármacos , Ergotioneína/farmacología , Melatonina/farmacología , Enfermedad de Alzheimer/metabolismo , Animales , Encéfalo/metabolismo , Encéfalo/patología , Cromatografía Líquida de Alta Presión , Modelos Animales de Enfermedad , Galactosa/toxicidad , Inmunohistoquímica , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Memoria/efectos de los fármacos , Trastornos de la Memoria/inducido químicamente , Ratones , Ratones Endogámicos C57BL , Estrés Oxidativo/efectos de los fármacosRESUMEN
OBJECTIVES: Using a nationwide population-based dataset to examine the risk of adverse pregnancy outcomes in women with systemic lupus erythematosus (SLE), with and without SLE hospitalisation during pregnancy. METHODS: We identified 1,010 pregnant women who had SLE during 2001 2003 as the study cohort and 5,050 randomly selected pregnant women (five for every woman with SLE) as a comparison cohort. Conditional logistic regression analyses were performed to explore the relationship between women with and without SLE and the risk of low birth weight (LBW), preterm birth, and babies small for gestational age (SGA), after adjusting for the characteristics of the infant, mother, and father. RESULTS: We found that there were significant differences in the risk of LBW (14.9% vs. 7.2%), preterm birth (14.4% vs. 8.5%), and SGA (28.5% vs. 17.5%) for women with SLE compared to women without. In addition, the adjusted odds of LBW, preterm birth, and SGA babies for women who had SLE during pregnancy were 6.15 (95% CI=4.15-9.13), 4.19 (95% CI=2.77-6.36), and 4.25 (95% CI=2.95-6.11) times, respectively, compared to women without any chronic illness. The adjusted odds of LBW, preterm birth, and SGA babies for women who had SLE but were not hospitalized during pregnancy were 1.80 (95% CI=1.43-2.26), 1.62 (95% CI=1.30-2.03), and 1.63 (95% CI=1.38-1.94) times, respectively, compared to unaffected mothers. CONCLUSIONS: We conclude that SLE can impact the pregnancy outcomes, especially if hospitalisation occurs during the pregnancy.
Asunto(s)
Hospitalización/estadística & datos numéricos , Lupus Eritematoso Sistémico/epidemiología , Complicaciones del Embarazo/epidemiología , Resultado del Embarazo/epidemiología , Adulto , Bases de Datos Factuales , Femenino , Humanos , Recién Nacido de Bajo Peso , Recién Nacido , Masculino , Programas Nacionales de Salud/estadística & datos numéricos , Embarazo , Nacimiento Prematuro/epidemiología , Factores de Riesgo , Taiwán/epidemiología , Adulto JovenRESUMEN
A novel type of alpha,beta-butenolide alkaloid, uncinine (1), two novel oxoaporphines, artabonatine C (2) and artabonatine D (3), a new oxazoloaporphine, artabonatine E (4), and a new 7,7'-bisdehydroaporphine, artabonatine F (5), along with 25 known alkaloids, were isolated from Artabotrys uncinatus. The structures of 1-5 were determined using NMR and mass spectral data. Atherospermidine and squamolone exhibited cytotoxicity against hepatocarcinoma cancer cell lines (Hep G(2) and 2,2,15), and the activity of some of the alkaloids in an antithrombin assay is also discussed.
Asunto(s)
Alcaloides/aislamiento & purificación , Annonaceae/química , Porfirinas/aislamiento & purificación , Alcaloides/química , Alcaloides/farmacología , Antitrombinas/metabolismo , Aporfinas/farmacología , Carcinoma Hepatocelular , Cromatografía en Capa Delgada , Ensayos de Selección de Medicamentos Antitumorales , Fibrinógeno/farmacología , Cromatografía de Gases y Espectrometría de Masas , Heparina/farmacología , Humanos , Isoquinolinas/farmacología , Espectroscopía de Resonancia Magnética , Medicina Tradicional China , Conformación Molecular , Estructura Molecular , Hojas de la Planta/química , Raíces de Plantas/química , Tallos de la Planta/química , Plantas Medicinales/química , Inhibidores de Agregación Plaquetaria/química , Inhibidores de Agregación Plaquetaria/aislamiento & purificación , Inhibidores de Agregación Plaquetaria/farmacología , Porfirinas/química , Porfirinas/farmacología , Espectrofotometría Infrarroja , Espectrofotometría Ultravioleta , Taiwán , Trombina/metabolismo , Células Tumorales Cultivadas/efectos de los fármacosRESUMEN
Salvia miltiorrhiza (Sm) administration has been shown to reduce hepatic fibrosis in rats. We investigated the hemodynamic effects of Sm on bile duct ligated (BDL) rats. Hemodynamic, histological, and vascular contractile studies were conducted in rats 4 weeks after bile duct ligation. An aqueous extract of Sm (0.2 g twice per day) or vehicle was administered for 4 weeks to BDL rats. Sm treatment in BDL rats significantly reduced histological grades of fibrosis and ameliorated the portal hypertensive state (including portal venous pressure, superior mesenteric artery blood flow, cardiac index, and total peripheral resistance) as compared with vehicle treatment. Moreover, Sm treatment enhanced the vascular sensitivity of mesenteric arteries to phenylephrine in BDL rats. Sm treatment had no effect on plasma biochemical profiles of either BDL or normal rats. Our results suggest that 4-week Sm treatment ameliorates the portal hypertensive state in BDL rats.
Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Hemodinámica/efectos de los fármacos , Cirrosis Hepática Experimental/tratamiento farmacológico , Cirrosis Hepática Experimental/fisiopatología , Fitoterapia , Salvia miltiorrhiza , Animales , Conductos Biliares , Bilirrubina/sangre , Colesterol/sangre , Medicamentos Herbarios Chinos/uso terapéutico , Hemodinámica/fisiología , Hipertensión Portal/tratamiento farmacológico , Técnicas In Vitro , Ligadura , Masculino , Arteria Mesentérica Superior/efectos de los fármacos , Arteria Mesentérica Superior/fisiología , Contracción Muscular/efectos de los fármacos , Fitoterapia/métodos , Ratas , Ratas Sprague-DawleyRESUMEN
A population's utilization of dental services is an important parameter in oral health care planning, which has rarely been studied in China. The objectives of this report were to describe the dental service utilization pattern of middle-aged and elderly Chinese and to analyze the influence of selected variables on the use of dental services. A Guangdong Province population of 1,573 35- to 44-year-olds and 1,515 65- to 74-year-olds recruited from urban and rural communities was interviewed in their local dialect. It was found that 23% of the middle-aged and 24% of the elderly subjects had visited a dentist within the preceding year. The two most commonly cited reasons for not having seen a dentist for at least 3 years were: no perceived need, and no serious dental problems. Among subjects who had visited a dentist within 3 years, the 3 most commonly received treatments were: fillings, extractions, and dental prostheses. Furthermore, a logistic regression analysis showed that women, subjects who lived in urban areas, were better educated, were wealthier, and had better oral health knowledge were more likely to be a recent dental service user. In conclusion, dental service utilization among the adult Southern Chinese was found to be low, problem-driven, and influenced by some socio-economic factors.
Asunto(s)
Servicios de Salud Dental/estadística & datos numéricos , Encuestas de Salud Bucal , Salud Bucal , Adulto , Anciano , Distribución de Chi-Cuadrado , China/epidemiología , Escolaridad , Femenino , Conductas Relacionadas con la Salud , Conocimientos, Actitudes y Práctica en Salud , Humanos , Entrevistas como Asunto , Modelos Logísticos , Masculino , Medicina Tradicional China , Persona de Mediana Edad , Características de la Residencia , Salud Rural/estadística & datos numéricos , Factores Sexuales , Factores Socioeconómicos , Encuestas y Cuestionarios , Salud Urbana/estadística & datos numéricosRESUMEN
Only recently have behavioral aspects been taken into consideration in oral health studies in China; thus, relevant information on perceptions in adult Chinese about oral health care is inadequate. In 1996-97, a large-scale oral epidemiological study was conducted in Southern China. Among its objectives were to describe the oral health knowledge, attitudes, and practices of the urban and rural adults living in Southern China and to analyze the influence of selected demographic and socio-economic factors. From 8 urban and 8 rural communities in Guangdong Province, 1,573 35- to 44-year-olds and 1,515 65- to 74-year-olds were sampled. Specially trained interviewers from the staff of local government or hospitals conducted face-to-face structured interviews. Almost all of the middle-aged and more than 90% of the dentate elderly surveyed claimed that they brushed their teeth every day and used toothpaste during toothbrushing, but awareness about fluoride content was lacking. The respondents had poor oral health knowledge but positive attitudes toward oral health, providing a basis for more community-based oral health education programs, especially targeting adults who are less-well-educated and have fewer socio-economic advantages.
Asunto(s)
Caries Dental/psicología , Conductas Relacionadas con la Salud , Conocimientos, Actitudes y Práctica en Salud , Salud Bucal , Enfermedades Periodontales/psicología , Adulto , Anciano , Análisis de Varianza , China/epidemiología , Caries Dental/epidemiología , Escolaridad , Femenino , Humanos , Entrevistas como Asunto , Modelos Logísticos , Masculino , Medicina Tradicional China , Enfermedades Periodontales/epidemiología , Salud Rural/estadística & datos numéricos , Estadísticas no Paramétricas , Encuestas y Cuestionarios , Cepillado Dental/estadística & datos numéricos , Salud Urbana/estadística & datos numéricosRESUMEN
BACKGROUND: Diffuse esophageal spasm (DES) is an uncommon condition that results in simultaneous esophageal contractions. Current medical treatment of DES is frequently unsatisfactory. We hypothesized that, as a smooth muscle relaxant, peppermint oil may improve the manometric findings in DES. STUDY: Eight consecutive patients with chest pain or dysphagia and who were found to have DES were enrolled during their diagnostic esophageal manometry. An eight-channel perfusion manometry system was used. Lower esophageal sphincter pressure and contractions of the esophageal body after 10 wet swallows were assessed before and 10 minutes after the ingestion of a solution containing five drops of peppermint oil in 10 mL of water. Each swallow was assessed for duration (seconds), amplitude (mm Hg), and proportion of simultaneous and multiphasic esophageal contractions. RESULTS: Lower esophageal sphincter pressures and contractile pressures and durations in both the upper and lower esophagus were no different before and after the peppermint oil. Peppermint oil completely eliminated simultaneous esophageal contractions in all patients (p < 0.01). The number of multiphasic, spontaneous, and missed contractions also improved. Because normal esophageal contractions are characteristically uniform in appearance, variability of esophageal contractions was compared before and after treatment. The variability of amplitude improved from 33.4 +/- 36.7 to 24.9 +/- 11.0 mm Hg (p < 0.05) after the peppermint oil. The variability for duration improved from 2.02 +/- 1.80 to 1.36 +/- 0.72 seconds (p < 0.01). Two of the eight patients had chest pain that resolved after the peppermint oil. CONCLUSIONS: This data demonstrates that peppermint oil improves the manometric features of DES.
Asunto(s)
Espasmo Esofágico Difuso/tratamiento farmacológico , Manometría , Parasimpatolíticos/administración & dosificación , Aceites de Plantas/administración & dosificación , Administración Oral , Adulto , Anciano , Anciano de 80 o más Años , Dolor en el Pecho/tratamiento farmacológico , Trastornos de Deglución/tratamiento farmacológico , Unión Esofagogástrica/efectos de los fármacos , Femenino , Humanos , Masculino , Mentha piperita , Persona de Mediana Edad , Peristaltismo/efectos de los fármacos , Resultado del TratamientoRESUMEN
Two new fatty abietane diterpenoids, oleoyl neocryptotanshinone (1) and oleoyl danshenxinkun A (2), were isolated as minor components from the roots of Salvia miltiorrhiza. Their structures were established on the basis of spectral evidence. In preliminary tests, they selectively inhibited rabbit platelet aggregation induced by arachidonic acid.
Asunto(s)
Diterpenos/química , Ácidos Oléicos/química , Plantas Medicinales/química , Inhibidores de Agregación Plaquetaria/química , Animales , China , Diterpenos/aislamiento & purificación , Diterpenos/farmacología , Hidrólisis , Técnicas In Vitro , Espectroscopía de Resonancia Magnética , Ácidos Oléicos/aislamiento & purificación , Ácidos Oléicos/farmacología , Raíces de Plantas/química , Agregación Plaquetaria/efectos de los fármacos , Inhibidores de Agregación Plaquetaria/aislamiento & purificación , Inhibidores de Agregación Plaquetaria/farmacología , Conejos , Espectrofotometría UltravioletaRESUMEN
Chronic diarrhea may occur when gastrointestinal transit is abnormally rapid. We hypothesized that oleic acid given prior to a meal would slow gastrointestinal transit and reduce diarrhea by activating nutrient-triggered inhibitory feedback mechanisms in the small intestine. Transit time was measured in eight normal subjects following ingestion of a control emulsion (0 ml oleic acid), and in 45 patients with chronic diarrhea following ingestion of emulsions containing 0, 1.6, and 3.2 ml oleic acid. Stool volume and frequency on and off treatment were compared. Transit time in normal subjects was 102.4 +/- 11.2 min (mean +/- SE). Transit times in patients was shorter at 29.3 +/- 2.8 min with the 0-ml dose (P < 0.001), but increased to 57.2 +/- 4.5 min with the 1.6-ml dose and to 83.3 +/- 5.2 min with the 3.2-ml dose (P < 0.001). In the 18 patients who provided stool records, frequency of bowel movements decreased from 6.9 +/- 0.8 to 5.4 +/- 0.9 bowel movements/24 hr (P < 0.05) and stool volume decreased from 1829.0 +/- 368.6 to 1322.5 +/- 256.9 ml/24 hr with treatment (P < 0.05). An emulsion containing oleic acid slowed gastrointestinal transit and reduced diarrhea by activating nutrient-triggered inhibitory feedback mechanisms in the small intestine.
Asunto(s)
Diarrea/tratamiento farmacológico , Tránsito Gastrointestinal/efectos de los fármacos , Ácido Oléico/uso terapéutico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Pruebas Respiratorias , Estudios de Casos y Controles , Enfermedad Crónica , Defecación/efectos de los fármacos , Diarrea/etiología , Diarrea/fisiopatología , Relación Dosis-Respuesta a Droga , Ingestión de Alimentos , Emulsiones , Retroalimentación , Femenino , Humanos , Hidrógeno/análisis , Intestino Delgado/efectos de los fármacos , Intestino Delgado/fisiopatología , Masculino , Persona de Mediana Edad , Ácido Oléico/farmacología , Factores de TiempoRESUMEN
While seizure attack is one of the serious complications during the hyperbaric oxygen (HBO) therapy, there is still no direct evidence showing that HBO can induce neuronal damage in the brain. The objective of this study was first to investigate whether HBO would lead to neurotoxicity in the primary rat cortical culture. Second, since alterations in neurotransmitters have been suggested in the pathophysiology of central nervous system (CNS) oxygen toxicity, the protective effects of the N-methyl-D-aspartate (NMDA) receptor antagonism and nitric oxide (NO) synthase inhibition on the HBO-induced neuronal damage were examined. The results showed that HBO exposure to 6 atmosphere absolute pressure (ATA) for 30, 60, and 90 min increased the lactate dehydrogenase (LDH) activity in the culture medium in a time-dependent manner. Accordingly, the cell survival, measured by the 3,(4,5-dimethyl-2-thiazolyl)2, 5-diphenyl-tetrazolium bromide (MTT) assay, was decreased after HBO exposure. Pretreatment with the NMDA antagonist MK-801 protected the cells against the HBO-induced damage. The protective effect was also noted in the cells pretreated with L-N(G)-nitro-arginine methyl ester, an NO synthase inhibitor. Thus, our results suggest that activation of NMDA receptors and production of NO play a role in the neurotoxicity produced by hyperbaric oxygen exposure.
Asunto(s)
Corteza Cerebral/efectos de los fármacos , Oxigenoterapia Hiperbárica/efectos adversos , Neuronas/efectos de los fármacos , Oxígeno/toxicidad , Animales , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Corteza Cerebral/metabolismo , Corteza Cerebral/patología , Medios de Cultivo Condicionados/metabolismo , Maleato de Dizocilpina/farmacología , Inhibidores Enzimáticos/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , L-Lactato Deshidrogenasa/metabolismo , NG-Nitroarginina Metil Éster/farmacología , Neuronas/metabolismo , Neuronas/patología , Fármacos Neuroprotectores/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo I , Presión , Ratas , Ratas Sprague-Dawley , Receptores de N-Metil-D-Aspartato/antagonistas & inhibidores , Sales de Tetrazolio , TiazolesRESUMEN
The abietane diterpenoid, neocryptotanshinone II, and the known 6,12-dihydroxyabieta-5,8,11,13-tetraen-7-one were isolated as minor components from the roots of Salvia miltiorrhiza. Their structures were established on the basis of spectral evidence.
Asunto(s)
Abietanos , Diterpenos/química , Diterpenos/aislamiento & purificación , Plantas Medicinales/química , Raíces de Plantas/químicaRESUMEN
Nitric oxide (NO) is a free-radical gas with a role in various signal transduction processes. In the CNS, NO acts as an important central nervous messenger, but in excess it may be neurotoxic. Chronic or high dose administration of D-amphetamine (AMPH) has been shown to induce striatal neurotoxicity in rodents and primates. In this study, we studied whether AMPH given systemically elicits NO formation in the striatum of rats and determined the relationship between NO formation and striatal DAergic terminal damage. Our results demonstrated that a single large dose administration of AMPH with desipramine elicited a delayed production of NO and concomitant long-term DA loss in the striatum. These phenomena were blocked by treatment with either the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) or the glutamate N-methyl-D-aspartate antagonist MK-801. It appears that AMPH-induced NO formation is critical for development of long-lasting DAergic terminal toxicity in the striatum of rats.
Asunto(s)
Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/metabolismo , Dextroanfetamina/farmacología , Dopaminérgicos/farmacología , Óxido Nítrico/biosíntesis , Animales , Antidepresivos Tricíclicos/farmacología , Desipramina/antagonistas & inhibidores , Desipramina/farmacología , Dextroanfetamina/antagonistas & inhibidores , Maleato de Dizocilpina/farmacología , Dopamina/metabolismo , Relación Dosis-Respuesta a Droga , Combinación de Medicamentos , Inhibidores Enzimáticos/farmacología , Inyecciones Intraperitoneales , Masculino , NG-Nitroarginina Metil Éster/farmacología , Terminaciones Nerviosas/efectos de los fármacos , Terminaciones Nerviosas/metabolismo , Fármacos Neuroprotectores/farmacología , Ratas , Ratas Sprague-Dawley , Factores de TiempoRESUMEN
Two minor acetophenones, 2,5-dihydroxy-4-methoxy-acetophenone (2) and 2,5-dihydroxy-4-methylacetophenone (7) from Paeonia species were found to selectively inhibit the aggregation of rabbit platelets induced by arachidonic acid. They were more potent than the major compound, paeonol (1), and 7 also inhibited the formation of TXA2 and PGD2 from arachidonic acid.
Asunto(s)
Acetofenonas/farmacología , Plantas Medicinales/química , Inhibidores de Agregación Plaquetaria/farmacología , Animales , Ácido Araquidónico/farmacología , Plaquetas/efectos de los fármacos , Plaquetas/fisiología , Técnicas In Vitro , Raíces de Plantas/química , ConejosRESUMEN
The present study examined the effects of nicotinamide on the D-amphetamine (AMPH)-induced dopamine (DA) depletion and energy metabolism change in the rat striatum. In chronic studies, co-administration of AMPH with desipramine, a drug that retards the metabolism of AMPH, (10 mg/kg, intraperitoneal [i.p.], respectively) caused a significant decrease of striatal DA content measured 7 days later. Pretreatment with nicotinamide (500 mg/kg, i.p.), the precursor molecule for the electron carrier molecule nicotinamide adenine dinucleotide (NAD), attenuated this effect of AMPH, whereas itself exerted no long-term effect on striatal DA content. In acute studies, a decrease in striatal adenosine triphospate/adenosine diphosphate (ATP/ADP) ratio was found 3 h after co-injection of AMPH and desipramine. However, nicotinamide pretreatment blocked the reduced striatal ATP/ADP ratio and resulted in a striking increase in striatal NAD content in AMPH-treated rats. Furthermore, nicotinamide was noted to increase striatal ATP/ADP ratio and NAD content in saline-treated rats. These findings suggest that nicotinamide protects against AMPH-induced DAergic neurotoxicity in the striatum of rats via energy supplement.
Asunto(s)
Cuerpo Estriado/metabolismo , Dextroanfetamina/farmacología , Dopamina/metabolismo , Metabolismo Energético/efectos de los fármacos , Niacinamida/farmacología , Animales , Cuerpo Estriado/efectos de los fármacos , Dextroanfetamina/antagonistas & inhibidores , Masculino , NAD/metabolismo , Ratas , Ratas Sprague-DawleyRESUMEN
BACKGROUND/AIMS: Somatostatin and its analogue have been shown to provide beneficial effects in the management of portal hypertension and hyperdynamic circulation. The current study was undertaken to evaluate the effects of lanreotide, a sustained-release somatostatin analogue, on hemodynamics in rats with portal hypertension. METHODS: Immediately after portal vein stenosis, rats were randomly assigned to receive vehicle or a single intramuscular injection of lanreotide 10 mg/kg. Hemodynamic measurements (radioactive microsphere technique) with portal systemic shunts determinations were performed on the 4th and 8th day after surgery, respectively. RESULTS: On the 4th day after surgery, rats treated with lanreotide had significantly lower cardiac index and higher systemic vascular resistance than rats treated with vehicle, while these values were no different on the 8th day after portal vein stenosis. In contrast, the elevation of portal pressure, portal tributary blood flow, and splanchnic fraction of cardiac output had ameliorated following lanreotide administration associated with an increase in splanchnic arterial resistance. Portal systemic shunts were lower in rats receiving lanreotide than in rats receiving vehicle. CONCLUSION: The current study showed that a single injection of sustained-release lanreotide in rats with portal vein stenosis delayed the development of peripheral arterial vasodilatation and hyperdynamic circulation, while it modified the evolution of portal hypertension and splanchnic hyperemia. This treatment also prevents, in part, the development of portal systemic shunts in rats with portal vein stenosis.
Asunto(s)
Hemodinámica/efectos de los fármacos , Péptidos Cíclicos/uso terapéutico , Vena Porta/efectos de los fármacos , Somatostatina/análogos & derivados , Animales , Constricción Patológica , Preparaciones de Acción Retardada , Evaluación Preclínica de Medicamentos , Glucagón/sangre , Inyecciones Intramusculares , Masculino , Microesferas , Ratas , Ratas Sprague-Dawley , Somatostatina/uso terapéuticoRESUMEN
OBJECTIVES: Cirrhotic patients with upper gastrointestinal bleeding are prone to bacterial infection. The aim of this study was to investigate the efficacy of prophylactic intestinal decontamination with oral ciprofloxacin for the prevention of bacterial infections in cirrhotic patients with upper gastrointestinal bleeding. METHODS: A total of 120 cirrhotic patients with acute upper gastrointestinal bleeding were enrolled. Sixty patients received ciprofloxacin 500 mg twice daily given orally or through nasogastric tube immediately after upper gastrointestinal endoscopic examination; drug administration continued for 7 days. The remaining 60 patients, who received placebo, served as controls. RESULTS: The incidence of proven bacterial infection in the ciprofloxacin-treated group was significantly lower than that of placebo group (10% vs 45%, p < 0.001). The incidences of bacteremia, spontaneous bacterial peritonitis, and urinary tract infection in the ciprofloxacin-treated group were significantly lower than those in the placebo group (0% vs 23%, 3.3% vs 13%, and 5% vs 18%, respectively; p < 0.05, respectively). Multivariate logistic regression analysis showed that a lack of prophylactic treatment with ciprofloxacin and severity of cirrhosis were the independent significant predictors for cirrhotic patients with acute gastrointestinal bleeding with infection. CONCLUSIONS: Prophylactic intestinal decontamination with oral ciprofloxacin is effective in the prevention of bacterial infections in patients with cirrhosis who were suffering from acute upper gastrointestinal hemorrhage.
Asunto(s)
Antiinfecciosos/uso terapéutico , Infecciones Bacterianas/prevención & control , Ciprofloxacina/uso terapéutico , Hemorragia Gastrointestinal/complicaciones , Cirrosis Hepática/complicaciones , Enfermedad Aguda , Administración Oral , Antiinfecciosos/administración & dosificación , Ciprofloxacina/administración & dosificación , Femenino , Humanos , Cirrosis Hepática Alcohólica/complicaciones , Masculino , Persona de Mediana Edad , Análisis de RegresiónRESUMEN
The stereochemistry of new acetophenones, cynandione B-D (2-4), isolated from Cynanchum taiwanianum, elucidated by computer modelling calculation and NOESY spectrum. It establishes the absolute configurations of cynandiones B-D (2-4) as 7R; 7"S, 7S; 7"S and 7R; 7"R, respectively. Cynandione B (2) strongly inhibited the release of beta-glucuronidase and lysozyme in formyl-methionyl-leucyl-phenylalanine (fMLP)-stimulated rat neutrophils in a concentration-dependent manner with IC50 values of 1.5 +/- 0.2 and 1.6 +/- 0.2 microM, respectively. 2,5-Dihydroxyacetophenone (6) strongly inhibited the aggregation of washed rabbit platelets induced by arachidonic acid in a concentration-dependent manner with an IC50 value of about 4.8 microM. In human citrated platelet-rich plasma, 2,5-dihydroxyacetophenone (6) inhibited the secondary phase, but not the primary phase, of aggregation induced by adrenaline and ADP. These results suggest that the antiplatelet effect of 2,5-dihydroxyacetophenone (6) is due to inhibition of the formation of thromboxane A2.